Cargando…
Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles
BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528138/ https://www.ncbi.nlm.nih.gov/pubmed/36184615 http://dx.doi.org/10.1186/s13195-022-01073-w |
_version_ | 1784801245576298496 |
---|---|
author | Yuyama, Kohei Sun, Hui Igarashi, Yasuyuki Monde, Kenji Hirase, Takumi Nakayama, Masato Makino, Yoichi |
author_facet | Yuyama, Kohei Sun, Hui Igarashi, Yasuyuki Monde, Kenji Hirase, Takumi Nakayama, Masato Makino, Yoichi |
author_sort | Yuyama, Kohei |
collection | PubMed |
description | BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs) are nanosized membrane vesicles released from a variety of cells and play important roles in cell–cell communication. Neuron-derived and ganglioside-enriched EVs capture amyloid-ß protein, a major AD agent, and transport it into glial cells for degradation; this suggests that EVs influence Aß accumulation in the brain. EV heterogeneity, however, requires the use of a highly sensitive technique for measuring specific EVs in biofluid. In this study, immuno-digital invasive cleavage assay (idICA) was developed for quantitating target-intact EVs. METHODS: EVs were captured onto ganglioside GM1-specific cholera toxin B subunit (CTB)-conjugated magnetic beads and detected with a DNA oligonucleotide-labeled Aß antibody. Fluorescence signals for individual EVs were then counted using an invasive cleavage assay (ICA). This idICA examines the Aß-bound and GM1-containing EVs isolated from the culture supernatant of human APP-overexpressing N2a (APP-N2a) cells and APP transgenic mice sera. RESULTS: The idICA quantitatively detected Aß-bound and GM1-containing EVs isolated from culture supernatants of APP-N2a cells and sera of AD model mice. The idICA levels of Aß-associated EVs in blood gradually increased from 3- to 12-month-old mice, corresponding to the progression of Aß accumulations in the brain of AD model mice. CONCLUSIONS: The present findings suggest that peripheral EVs harboring Aß and GM1 reflect Aß burden in mice. The idICA is a valuable tool for easy quantitative detection of EVs as an accessible biomarker for preclinical AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01073-w. |
format | Online Article Text |
id | pubmed-9528138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95281382022-10-04 Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles Yuyama, Kohei Sun, Hui Igarashi, Yasuyuki Monde, Kenji Hirase, Takumi Nakayama, Masato Makino, Yoichi Alzheimers Res Ther Research BACKGROUND: The protracted preclinical stage of Alzheimer’s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs) are nanosized membrane vesicles released from a variety of cells and play important roles in cell–cell communication. Neuron-derived and ganglioside-enriched EVs capture amyloid-ß protein, a major AD agent, and transport it into glial cells for degradation; this suggests that EVs influence Aß accumulation in the brain. EV heterogeneity, however, requires the use of a highly sensitive technique for measuring specific EVs in biofluid. In this study, immuno-digital invasive cleavage assay (idICA) was developed for quantitating target-intact EVs. METHODS: EVs were captured onto ganglioside GM1-specific cholera toxin B subunit (CTB)-conjugated magnetic beads and detected with a DNA oligonucleotide-labeled Aß antibody. Fluorescence signals for individual EVs were then counted using an invasive cleavage assay (ICA). This idICA examines the Aß-bound and GM1-containing EVs isolated from the culture supernatant of human APP-overexpressing N2a (APP-N2a) cells and APP transgenic mice sera. RESULTS: The idICA quantitatively detected Aß-bound and GM1-containing EVs isolated from culture supernatants of APP-N2a cells and sera of AD model mice. The idICA levels of Aß-associated EVs in blood gradually increased from 3- to 12-month-old mice, corresponding to the progression of Aß accumulations in the brain of AD model mice. CONCLUSIONS: The present findings suggest that peripheral EVs harboring Aß and GM1 reflect Aß burden in mice. The idICA is a valuable tool for easy quantitative detection of EVs as an accessible biomarker for preclinical AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01073-w. BioMed Central 2022-10-03 /pmc/articles/PMC9528138/ /pubmed/36184615 http://dx.doi.org/10.1186/s13195-022-01073-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yuyama, Kohei Sun, Hui Igarashi, Yasuyuki Monde, Kenji Hirase, Takumi Nakayama, Masato Makino, Yoichi Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title | Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title_full | Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title_fullStr | Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title_full_unstemmed | Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title_short | Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles |
title_sort | immuno-digital invasive cleavage assay for analyzing alzheimer’s amyloid ß-bound extracellular vesicles |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528138/ https://www.ncbi.nlm.nih.gov/pubmed/36184615 http://dx.doi.org/10.1186/s13195-022-01073-w |
work_keys_str_mv | AT yuyamakohei immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT sunhui immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT igarashiyasuyuki immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT mondekenji immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT hirasetakumi immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT nakayamamasato immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles AT makinoyoichi immunodigitalinvasivecleavageassayforanalyzingalzheimersamyloidßboundextracellularvesicles |